Article Text

Download PDFPDF
If it’s ‘only’ asthma, why are children still dying?

Statistics from


  • Contributors The original outline plan for the manuscript was developed by all authors. The initial draft manuscript was prepared by WC and this was circulated to all authors who provided references and additional content. Editorial assistance and manuscript preparation was then undertaken by a medical writer before a final draft was circulated for further comment of all authors. The raw data concerning referral thresholds for healthcare professionals in primary and secondary care was provided by Novartis Pharmaceuticals, who also paid for the services of the medical writer. The paper was reviewed by Dr Adam Strong of Novartis prior to submission to ensure that it was compliant with ABPI regulations.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests WC reports personal fees for lecturing and advisory board work from: GlaxoSmithKline, Trudell Medical International, Orion Medical and Novartis Pharmaceuticals. SC has received funding from Astra Zeneca, GlaxoSmithKline, Napp, Novartis, Teva and Circassia. SF has received funding from Novartis and is co-treasurer of the Severe Asthma Nurses Network which organises conferences for professional development. AG reports fees for lecturing/advisory board work from: GlaxoSmithKline, Novartis Pharmaceuticals, Boehringer Ingelheim and Astra Zeneca. He has been CI/PI of the the clinical trials with GlaxoSmithKline, Novartis Pharmaceuticals, Boehringer Ingelheim, & Airosnett for which his institution has been paid. He is also a director of the non-profit organisation Paediatric Respiratory Academy which organises educational meetings. SH works as a GP, he is funded for 1/2 session per week as a clinical commissioner, has received funding from Astra Zeneca, Beximco, Boehringer Ingelheim, Chiesi, Glaxo Smith Kline, Johnson and Johnson, Mylan, Napp, Novartis, Nutricia, Orion, Pfizer, Sandoz, Teva and Trudell Medical International. PN has received funding from Novartis. ML reports personal fees from: Clement Clarke International, Teva, Astra Zeneca, Chiesi, Orion Pharmaceuticals, Napp Pharmaceuticals, Soar Beyond, Trudell Pharmaceuticals, National Services for Health Improvement, a company providing services for practices (Nurse asthma Reviews), Novartis Pharmaceuticals, GlaxoSmithKline, reimbursement of travel and accommodation support from GINA, grants from Conzorcio Futuro In Ricerca, personal fees from, non-financial support from Asthma and COPD (Joint) Lead for Whole Systems Integrated Care (WSIC) NorthWest London.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement All data relevant to the study are included in the article or uploaded as supplementary information.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.